Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 19 studies | 22% ± 6% | |
| memory B cell | 13 studies | 21% ± 4% | |
| type I pneumocyte | 8 studies | 22% ± 6% | |
| oligodendrocyte | 7 studies | 21% ± 7% | |
| naive B cell | 5 studies | 17% ± 1% | |
| classical monocyte | 5 studies | 24% ± 10% | |
| endothelial cell | 5 studies | 26% ± 10% | |
| epithelial cell | 5 studies | 28% ± 8% | |
| squamous epithelial cell | 4 studies | 34% ± 17% | |
| non-classical monocyte | 4 studies | 31% ± 14% | |
| ciliated cell | 4 studies | 22% ± 3% | |
| glutamatergic neuron | 4 studies | 29% ± 9% | |
| macrophage | 4 studies | 19% ± 2% | |
| hematopoietic precursor cell | 3 studies | 25% ± 5% | |
| microglial cell | 3 studies | 22% ± 3% | |
| germinal center B cell | 3 studies | 28% ± 3% | |
| GABAergic neuron | 3 studies | 36% ± 4% | |
| neutrophil | 3 studies | 18% ± 2% | |
| club cell | 3 studies | 24% ± 6% | |
| basal cell | 3 studies | 23% ± 3% | |
| interneuron | 3 studies | 35% ± 19% | |
| astrocyte | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4644.76 | 1445 / 1445 | 100% | 25.76 | 183 / 183 |
| kidney | 100% | 3603.64 | 89 / 89 | 100% | 40.95 | 901 / 901 |
| thymus | 100% | 6291.21 | 653 / 653 | 100% | 38.80 | 605 / 605 |
| uterus | 100% | 2977.98 | 170 / 170 | 100% | 25.10 | 459 / 459 |
| lung | 100% | 5034.91 | 578 / 578 | 100% | 26.30 | 1154 / 1155 |
| breast | 100% | 3414.77 | 459 / 459 | 100% | 23.77 | 1116 / 1118 |
| bladder | 100% | 4978.10 | 21 / 21 | 100% | 23.96 | 503 / 504 |
| prostate | 100% | 3908.98 | 245 / 245 | 100% | 21.44 | 501 / 502 |
| stomach | 100% | 2731.16 | 359 / 359 | 99% | 20.50 | 284 / 286 |
| skin | 100% | 6663.28 | 1809 / 1809 | 99% | 27.42 | 467 / 472 |
| intestine | 100% | 4035.58 | 966 / 966 | 99% | 18.13 | 520 / 527 |
| ovary | 100% | 3651.39 | 180 / 180 | 98% | 19.64 | 423 / 430 |
| brain | 97% | 2199.06 | 2571 / 2642 | 100% | 22.48 | 705 / 705 |
| pancreas | 97% | 1764.63 | 319 / 328 | 98% | 21.03 | 175 / 178 |
| liver | 100% | 1702.00 | 225 / 226 | 95% | 13.02 | 384 / 406 |
| adrenal gland | 100% | 2873.14 | 258 / 258 | 85% | 9.71 | 195 / 230 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 71.05 | 29 / 29 |
| spleen | 100% | 7143.30 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 26.47 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 16.78 | 1 / 1 |
| blood vessel | 100% | 3951.20 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 2917.95 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| peripheral blood | 100% | 8722.01 | 927 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 18.02 | 79 / 80 |
| heart | 92% | 1727.63 | 788 / 861 | 0% | 0 | 0 / 0 |
| muscle | 66% | 772.66 | 530 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1905667 | Biological process | negative regulation of protein localization to endosome |
| GO_0002091 | Biological process | negative regulation of receptor internalization |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| GO_0005770 | Cellular component | late endosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0140036 | Molecular function | ubiquitin-modified protein reader activity |
| Gene name | ANKRD13A |
| Protein name | Ankyrin repeat domain-containing protein 13A (Protein KE03) Ankyrin repeat domain 13A |
| Synonyms | ANKRD13 |
| Description | FUNCTION: Ubiquitin-binding protein that specifically recognizes and binds 'Lys-63'-linked ubiquitin. Does not bind 'Lys-48'-linked ubiquitin. Positively regulates the internalization of ligand-activated EGFR by binding to the Ub moiety of ubiquitinated EGFR at the cell membrane. . |
| Accessions | F8W150 ENST00000547639.5 S4R3U2 ENST00000553025.5 ENST00000551491.1 H0YIN8 Q8IZ07 ENST00000547419.6 ENST00000261739.9 S4R3D2 |